Dr Reddy's voluntarily recalls 4 drugs from U.S.

BANGALORE, Sept 30 (Reuters) - Indian drug maker Dr Reddy's Laboratories Ltd (REDY.BO) said on Wednesday it had voluntarily recalled four products from its key U.S. market as they had been observed to contain some oversized tablets. The company said it saw no material financial impact from the recall and it was being conducted with the knowledge of the U.S. Food and Drug Administration. (Reporting by Sumeet Chatterjee; Editing by Ranjit Gangadharan)